[140] evaluated the impact of a nutraceutical supplement containing ALA (BETTERAL ), as the primary functional ingredient, plus GLA, B vitamins, vitamin E, and selenium on serum paraoxonase-1 (PON-1) lactonase activity in patients recovering from acute stroke
Lenmeldy is the first FDA-approved gene therapy for MLD, which is caused by a deficiency of the arylsulfatase A (ARSA) enzyme, a state that leads to a buildup of fatty substances in the cells
Il suo profilo di sicurezza ben caratterizzato e la sua presenza naturale nell'organismo ne fanno un candidato particolarmente interessante per formulazioni cosmetiche e applicazioni nella medicina rigenerativa cutanea
A medical professional provides personalized recommendations based on individual health conditions and ensures that acetaminophen is used safely
Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value